Quarterly report pursuant to sections 13 or 15(d)

Statements of Operations

v2.4.0.6
Statements of Operations (USD $)
3 Months Ended 5 Months Ended 6 Months Ended 18 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2010
Dec. 31, 2011
Dec. 31, 2011
Operating Expenses          
Research and development     $ 24,500   $ 24,500
General and administrative 7,998 1,751 2,251 15,392 32,819
Total Operating Expenses 7,998 1,751 26,751 15,392 57,319
Net loss $ (7,998) $ (1,751) $ (26,751) $ (15,392) $ (57,319)
Net loss per common share - basic and diluted $ 0.00 $ 0.00 $ (0.03) $ 0.00 $ (0.02)
Weighted average number of common shares outstanding during the period - basic and diluted 3,836,000 3,069,473 808,168 3,836,000 3,485,300